Hematology & Oncology in Duarte, CA
37 verified hematology & oncology doctors in Duarte.
Hematologist-oncologists treat blood disorders and cancers, coordinating chemotherapy and blood-related care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Manana Elia, MD
Hematology & Oncology
CMS Open Payments· $152.17 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$152.17
Total received
6
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 51th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Manana Elia do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Leslie Popplewell, MD
Hematology & Oncology
CMS Open Payments· $253,934 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$253,934
Total received
33
Transactions
6
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Leslie Popplewell do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joseph Alvarnas, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michael Rosenzweig, MD
Hematology & Oncology
CMS Open Payments· $375,761 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$375,761
Total received
100
Transactions
10
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Michael Rosenzweig do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Seda Barzegar, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Alexandra Levine, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Figlin, MD
Hematology & Oncology
CMS Open Payments· $1,008,491 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,008,491
Total received
29
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Robert Figlin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Cathie Chung, MD
Hematology & Oncology
CMS Open Payments· $1,517 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,517
Total received
4
Transactions
2
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 69th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Cathie Chung do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Peter Curtin, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Lihua Budde, MD
Hematology & Oncology
CMS Open Payments· $5,765,898 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$5,765,898
Total received
96
Transactions
14
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Lihua Budde do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Tanya Dorff, MD
Hematology & Oncology
CMS Open Payments· $414,310 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$414,310
Total received
57
Transactions
18
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Tanya Dorff do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Andrew Artz, MD
Hematology & Oncology
CMS Open Payments· $165.06 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$165.06
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 52th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Andrew Artz do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jasmine Zain, MD
Hematology & Oncology
CMS Open Payments· $248,520 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$248,520
Total received
38
Transactions
14
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Jasmine Zain do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ryotaro Nakamura, MD
Hematology & Oncology
CMS Open Payments· $41,039 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$41,039
Total received
10
Transactions
6
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Ryotaro Nakamura do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Christine Lovly, MD
Hematology & Oncology
CMS Open Payments· $64,199 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$64,199
Total received
47
Transactions
15
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Christine Lovly do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Forrest Stewart, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Theresa Harned, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Jenq, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Angela Lopez, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Murali Janakiram, MD
Hematology & Oncology
CMS Open Payments· $183,457 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$183,457
Total received
20
Transactions
7
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Murali Janakiram do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jyoti Malhotra, MD
Hematology & Oncology
CMS Open Payments· $78,486 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$78,486
Total received
50
Transactions
12
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Jyoti Malhotra do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Samer Khaled, MD
Hematology & Oncology
CMS Open Payments· $19.05 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19.05
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 39th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Samer Khaled do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Karamjeet Sandhu, MD
Hematology & Oncology
CMS Open Payments· $150.15 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$150.15
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 51th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Karamjeet Sandhu do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Nitya Nathwani, MD
Hematology & Oncology
CMS Open Payments· $162,259 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$162,259
Total received
19
Transactions
2
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Nitya Nathwani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Scott James, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Geoffrey Shouse, DO
Hematology & Oncology
CMS Open Payments· $99,830 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$99,830
Total received
44
Transactions
6
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Geoffrey Shouse do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Niloufer Khan, MD
Hematology & Oncology
CMS Open Payments· $1,014,411 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,014,411
Total received
12
Transactions
2
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Niloufer Khan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Aditya Shreenivas, MD
Hematology & Oncology
CMS Open Payments· $188,364 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$188,364
Total received
6
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Aditya Shreenivas do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vaibhav Agrawal, MD
Hematology & Oncology
CMS Open Payments· $420,404 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$420,404
Total received
7
Transactions
5
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Vaibhav Agrawal do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Christina Poh, MD
Hematology & Oncology
CMS Open Payments· $377,457 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$377,457
Total received
56
Transactions
11
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Christina Poh do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Nikhila Kethireddy, MD
Hematology & Oncology
CMS Open Payments· $214.13 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$214.13
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Nikhila Kethireddy do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Alexandra Wong, MD
Hematology & Oncology
CMS Open Payments· $1,692 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,692
Total received
60
Transactions
14
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 70th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Alexandra Wong do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Adam Braun, MD
Hematology & Oncology
CMS Open Payments· $805.80 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$805.80
Total received
9
Transactions
8
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Adam Braun do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Peter Zang, MD
Hematology & Oncology
CMS Open Payments· $227.77 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$227.77
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 55th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Peter Zang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Austin Kordic, MD
Hematology & Oncology
CMS Open Payments· $301.10 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$301.10
Total received
6
Transactions
6
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 57th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Austin Kordic do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vikramjit Dhillon, DO
Hematology & Oncology
CMS Open Payments· $72.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$72.18
Total received
3
Transactions
2
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 46th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Vikramjit Dhillon do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rick Lin, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.